Similar to these data, Wang X et al. found that PRDX1 is more abundant in breast cancer cell lines (including ER+ and ER‐) than in normal or pseudonormal breast cell lines, but not found a significant difference in PRDX1 levels between ER+ and ER‐ breast cancer cell lines 50. This evidence concerns the gene PRDX1 and breast carcinoma.